Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)

Basit Öğe Kaydı
dc.contributor.authorSönmez, Alper
dc.contributor.authorHaymana, Cem
dc.contributor.authorBayram, Fahri
dc.contributor.authorSalman, Serpil
dc.contributor.authorDizdar, Oğuzhan Sıtkı
dc.contributor.authorGürkan, Eren
dc.contributor.authorKargılı Çarlıoğlu, Ayşe
dc.contributor.authorKüçükler, Ferit Kerim
dc.date.accessioned2019-05-10T09:39:38Z
dc.date.available2019-05-10T09:39:38Z
dc.date.issued2018
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractAims: Turkey has the highest prevalence of diabetes in Europe. It is therefore essential to know the overall cardiovascular risk and reveal the predictors of metabolic control in Turkish adults with diabetes mellitus. Methods: A nationwide, multicenter survey consecutively enrolled patients who were under follow up for at least a year. Optimal control was defined as HbA1c < 7%, home arterial blood pressure (ABP) < 135/85 mmHg, or LDL-C < 100 mg/dL. Achieving all parameters indicated triple metabolic control. Results: HbA1c levels of patients (n = 5211) were 8.6 ± 1.9% (71 ± 22 mmol/mol) and 7.7 ± 1.7% (61 ± 19 mmol/mol), in Type 1 and Type 2 diabetes, respectively. Glycemic control was achieved in 15.3% and 40.2%, and triple metabolic control was achieved in 5.5% and 10.1%, respectively. Only 1.5% of patients met all the criteria of being non-obese, non-smoker, exercising, and under triple metabolic control. Low education level was a significant predictor of poor glycemic control in both groups. Conclusions: Few patients with Type 2, and even fewer with Type 1 diabetes have optimal metabolic control in Turkey. TEMD study will provide evidence-based information to policy makers to focus more on the quality and sustainability of diabetes care in order to reduce the national burden of the disease. © 2018 Elsevier B.V.
dc.identifier.citationSonmez, A., Haymana, C., Bayram, F., Salman, S., Dizdar, O. S., Gurkan, E., ... & Guldiken, S. (2018). Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study). Diabetes research and clinical practice, 146, 138-147.
dc.identifier.doi10.1016/j.diabres.2018.09.010
dc.identifier.endpage147en_US
dc.identifier.issn0168-8227
dc.identifier.scopusqualityQ1
dc.identifier.startpage138en_US
dc.identifier.urihttps://doi.org/10.1016/j.diabres.2018.09.010
dc.identifier.urihttps://hdl.handle.net/11491/743
dc.identifier.volume146en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofDiabetes Research and Clinical Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectArterial Blood Pressureen_US
dc.subjectHbA1cen_US
dc.subjectLDL-Cholesterolen_US
dc.subjectType 1 Diabetesen_US
dc.subjectType 2 Diabetesen_US
dc.titleTurkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu